NCT02361138View on ClinicalTrials.gov

The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Type 2 Diabetes
Interventions
DRUG

SHR3824

DRUG

Placebo

Trial Locations (1)

200030

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02361138 - The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers | Biotech Hunter | Biotech Hunter